Osteoporosis Tablet Franchise in Ahmedabad

Name: Risenet 35 Tablet (Risedronate 35 mg Tablet)
Brand: Risenet 35 Tablet
Rating: 4.8 (150 reviews)

Bone Health Medicine Supplier in Mumbai

Ortho Tablet Distributor in Delhi

Risedronate Tablet Manufacturer in Bangalore

Bone Strength Tablet Stockist in Hyderabad

Osteoporosis Medicine Exporter in Chandigarh

Home/Products /risedronate-35mg-tablet

Therapeutic

ENDOCRINOLOGY and Hormonal range

Gastroenterology

General and OTC medicines

Gynecology and Fertility

Hepatology

Hypertension/ Blood Pressure

Nutraceuticals, Multivitamins and Multiminerals

Sedative or Antianxiety

Risedronate 35 mg Tablet – PCD Pharma Franchise Marketing Material

Risenet 35 Tablet

Composition : Risedronate (35mg) Tablet

Dosage Form : Tablet

Packaging Type : Blister

Packaging : 10x4

Price : ₹1/-

Contact For Business Query

Risenet 35 Tablet containing Risedronate is used for the treatment of osteoporosis. It helps in strengthening bones, improving bone density, and reducing the risk of fractures.

Risedronate works by slowing down bone loss and maintaining bone strength by inhibiting osteoclast activity, which helps in preserving bone structure and density.

The tablet is widely prescribed for post-menopausal osteoporosis and bone-related conditions, leading to consistent demand and long-term usage in orthopedic practice.

With increasing cases of bone disorders and aging population, this product offers strong business potential for retailers and distributors. Its long-term therapy requirement, steady prescription demand, and essential role in bone health management make it a reliable product for consistent sales and growth in the orthopedic segment.

About the Product

Risenet 35 Tablet containing Risedronate is used for the treatment of osteoporosis. It helps in strengthening bones, improving bone density, and reducing the risk of fractures.

Risedronate works by slowing down bone loss and maintaining bone strength by inhibiting osteoclast activity, which helps in preserving bone structure and density.

The tablet is widely prescribed for post-menopausal osteoporosis and bone-related conditions, leading to consistent demand and long-term usage in orthopedic practice.

Some patients may experience abdominal pain, heartburn, nausea, constipation, or musculoskeletal pain. Rarely, esophageal irritation, jaw problems (osteonecrosis), or atypical fractures may occur with long-term use.

Risenet 35 Tablet is indicated for the treatment and prevention of osteoporosis in postmenopausal women and in men at risk of fractures. It is also used in conditions like glucocorticoid-induced osteoporosis. It helps increase bone strength, reduce bone breakdown, and lower the risk of vertebral and non-vertebral fractures.

This medicine should be used under medical supervision. It should be taken exactly as directed, usually on an empty stomach with water, and the patient should remain upright for at least 30 minutes after intake. Calcium or antacid supplements should not be taken immediately with this medicine.

Store in a cool, dry place below 25°C, protected from moisture and direct sunlight. Keep the tablets in their original packaging and out of reach of children.